XML 32 R19.htm IDEA: XBRL DOCUMENT
v3.22.1

Earnings (Loss) Per Share | 6 Months Ended
--- | ---
Feb. 28, 2022
Earnings Per Share [Abstract] |
Earnings (Loss) Per Share | Note 10 – Earnings (Loss) Per Share The shares used in the computation of basic and diluted earnings (loss) per common share are reconciled as follows:
| Three Months Ended February 28, |  |  | Six Months Ended February 28, |
(In thousands) | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
Weighted average basic common shares outstanding (1) |  | 32,582 |  |  |  | 32,810 |  |  |  | 32,546 |  |  |  | 32,766 |
Dilutive effect of 2.875% convertible notes due 2024 (2) (3) |  | 815 |  |  |  | — |  |  |  | — |  |  |  | — |
Dilutive effect of 2.875% convertible notes due 2028 (4) |  | — |  |  | N/A |  |  |  | — |  |  | N/A |
Dilutive effect of 2.25% convertible notes due 2024 (2) (5) | N/A |  |  |  | — |  |  | N/A |  |  |  | — |
Dilutive effect of restricted stock units (2) (6) |  | 1,066 |  |  |  | — |  |  |  | 1,063 |  |  |  | — |
Weighted average diluted common shares outstanding |  | 34,463 |  |  |  | 32,810 |  |  |  | 33,609 |  |  |  | 32,766 |
(1) Restricted stock grants and restricted stock units that are considered participating securities, including some grants subject to certain performance criteria, are included in weighted average basic common shares outstanding when the Company is in a net earnings position. (2) The dilutive effect of common stock equivalents was excluded from the share calculation for the three and six months ended February 28, 2021 due to a net loss. (3) The dilutive effect of the 2.875% Convertible notes due 2024 was excluded for the six months ended February 28, 2022 as they were considered anti-dilutive under the “if converted” method as further discussed below. (4) The dilutive effect of the 2.875% Convertible notes due 2028 was excluded for the three and six months ended February 28, 2022 as the average stock price was less than the applicable conversion price and therefore was considered anti-dilutive. As these notes require cash settlement for the principal, only the premium is dilutive under the "if converted" method as further discussed below. These convertible notes were issued in April 2021. (5) The 2.25% Convertible notes due 2024 were retired in April 2021. (6) Restricted stock units that are not considered participating securities and restricted stock units subject to performance criteria, for which actual levels of performance above target have been achieved, are included in weighted average diluted common shares outstanding when the Company is in a net earnings position. Basic earnings (loss) per common share (EPS) is computed by dividing Net earnings (loss) attributable to Greenbrier by weighted average basic common shares outstanding, which includes restricted stock grants and restricted stock units that are considered participating securities when the Company is in a net earnings position. The Company's approach for calculating diluted EPS was modified beginning September 1, 2021 upon the adoption of Accounting Standard Update 2020-06, Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. See Note 1 - Interim Financial Statements for additional information. For the three and six months ended February 28, 2022, diluted EPS was calculated using the more dilutive of two methods. The first method includes the dilutive effect, using the treasury stock method, associated with restricted stock units that are not considered participating securities and performance based restricted stock units subject to performance criteria, for which actual levels of performance above target have been achieved. The second method supplements the first by also including the “if converted” effect of the 2.875% Convertible notes due 2024 and shares underlying the 2.875% Convertible notes due 2028, when there is a conversion premium. Under the “if converted” method, debt issuance and interest costs, both net of tax, associated with the convertible notes due 2024 are added back to net earnings and the share count is increased by the shares underlying the convertible notes. For the three and six months ended February 28, 2021, diluted EPS was calculated using the treasury stock method associated with shares underlying the 2.875% Convertible notes due 2024, 2.25% convertible notes due 2024, restricted stock units that are not considered participating securities and performance based restricted stock units subject to performance criteria, for which actual levels of performance above target have been achieved. The dilutive effect of common stock equivalents was excluded from the share calculation for the three and six months ended February 28, 2021 due to a net loss.
| Three Months Ended February 28, |  |  | Six Months Ended February 28, |
(in millions, except shares which are reflected in thousands, and per share amounts) | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
Net earnings (loss) attributable to Greenbrier | $ | 12.8 |  |  | $ | (9.1 | ) |  | $ | 23.6 |  |  | $ | (19.1 | )
Weighted average basic common shares outstanding |  | 32,582 |  |  |  | 32,810 |  |  |  | 32,546 |  |  |  | 32,766 |
Basic earnings (loss) per share | $ | 0.39 |  |  | $ | (0.28 | ) |  | $ | 0.72 |  |  | $ | (0.58 | )
Net earnings (loss) attributable to Greenbrier | $ | 12.8 |  |  | $ | (9.1 | ) |  | $ | 23.6 |  |  | $ | (19.1 | )
Add back: |  |  |  |  |  |  |  |  |  |  |
Interest and debt issuance costs on the 2.875% convertible notes due 2024, net of tax |  | 0.3 |  |  | n/a |  |  | n/a |  |  | n/a |
Earnings before interest and debt issuance costs on the 2.875% convertible notes due 2024 | $ | 13.1 |  |  | n/a |  |  | n/a |  |  | n/a |
Weighted average diluted common shares outstanding |  | 34,463 |  |  |  | 32,810 |  |  |  | 33,609 |  |  |  | 32,766 |
Diluted earnings (loss) per share | $ | 0.38 |  | (1) | $ | (0.28 | ) |  | $ | 0.70 |  |  | $ | (0.58 | )
(1) Diluted earnings per share was calculated as follows: Earnings before interest and debt issuance costs on the 2.875% convertible notes due 2024 Weighted average diluted common shares outstanding

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration